Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205491 · ClinicalTrials.gov registry record · Phase 4
Pharmacological Intervention in Depression After Traumatic Brain Injury
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00205491 is a Phase 4 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 100 participants.
The verdict
NCT00205491, a Phase 4 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if treatment with venlafaxine reduces symptoms of depression in persons with traumatic brain injury.
Interventions
- DRUG Venlafaxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205491
The ClinicalTrials.gov registry entry for NCT00205491 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venlafaxine is the first listed.
NCT00205491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205491 about?
NCT00205491 is a clinical study titled "Pharmacological Intervention in Depression After Traumatic Brain Injury". The purpose of this study is to determine if treatment with venlafaxine reduces symptoms of depression in persons with traumatic brain injury.
What is the current status of trial NCT00205491?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2004-10. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00205491?
The interventions under investigation include: Venlafaxine (DRUG).
Who is sponsoring clinical trial NCT00205491?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.